These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2). Dowd PM; Martin MF; Cooke ED; Bowcock SA; Jones R; Dieppe PA; Kirby JD Br J Dermatol; 1982 Jan; 106(1):81-9. PubMed ID: 7037038 [No Abstract] [Full Text] [Related]
4. [Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative]. Keller J; Kaltenecker A; Schricker KT; Krais T; Schönberger A; Gevatter M; Hornstein OP Dtsch Med Wochenschr; 1984 Sep; 109(38):1433-8. PubMed ID: 6383760 [TBL] [Abstract][Full Text] [Related]
5. Evidence for the Use of Epoprostenol to Treat Raynaud's Phenomenon With or Without Digital Ulcers. Cruz JE; Ward A; Anthony S; Chang S; Bae HB; Hermes-DeSantis ER Ann Pharmacother; 2016 Dec; 50(12):1060-1067. PubMed ID: 27465880 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue. Yardumian DA; Isenberg DA; Rustin M; Belcher G; Snaith ML; Dowd PM; Machin SJ Br J Rheumatol; 1988 Jun; 27(3):220-6. PubMed ID: 2454140 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of severe Raynaud syndrome in scleroderma or thromboangiitis obliterans with prostacyclin (prostaglandin I2)]. Rüthlein HJ; Riegger G; Auer IO Z Rheumatol; 1991; 50(1):16-20. PubMed ID: 2058317 [TBL] [Abstract][Full Text] [Related]
8. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma. Colakoğlu M; Cobankara V; Akpolat T Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574 [TBL] [Abstract][Full Text] [Related]
9. [Trial treatment of severe Raynaud's phenomenon with prostacyclin (PGI2)]. Cabane J; Boue F; Godeau P; Lecompte T; Charpentier MC; Samama M; Nebout T Rev Med Interne; 1985 Dec; 6(5):581-9. PubMed ID: 3914023 [TBL] [Abstract][Full Text] [Related]
15. [A study of Raynaud's syndrome using dynamic infrared thermography]. Shcherbakov AB; Koreneva LG; Markov AG Revmatologiia (Mosk); 1990; (2):7-11. PubMed ID: 2218268 [TBL] [Abstract][Full Text] [Related]
16. Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. McHugh NJ; Csuka M; Watson H; Belcher G; Amadi A; Ring EF; Black CM; Maddison PJ Ann Rheum Dis; 1988 Jan; 47(1):43-7. PubMed ID: 2449871 [TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud's phenomenon: the acute vasodilatory effect is not sustained. Kingma K; Wollersheim H; Thien T J Cardiovasc Pharmacol; 1995 Sep; 26(3):388-93. PubMed ID: 8583779 [TBL] [Abstract][Full Text] [Related]
19. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol. Milio G; Corrado E; Genova C; Amato C; Raimondi F; Almasio PL; Novo S Rheumatology (Oxford); 2006 Aug; 45(8):999-1004. PubMed ID: 16484290 [TBL] [Abstract][Full Text] [Related]